In reply-Commercial Cannabidiol Caution: A New Gold Rush

Affiliations

¹ Creighton University School of Medicine, Omaha, NE.
² Division of General Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN.

Comment

Harrison J VanDolah et al. Mayo Clin Proc. 2020 Jan.

. 2020 Jan;95(1):200-201.

doi: 10.1016/j.mayocp.2019.10.025.

¹ Creighton University School of Medicine, Omaha, NE.
² Division of General Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN.

No abstract available

Comment on

Clinicians' Guide to Cannabidiol and Hemp Oils.
VanDolah HJ, Bauer BA, Mauck KF. VanDolah HJ, et al. Mayo Clin Proc. 2019 Sep;94(9):1840-1851. doi: 10.1016/j.mayocp.2019.01.003. Epub 2019 Aug 22. Mayo Clin Proc. 2019. PMID: 31447137 Review.
Commercial Cannabidiol Caution: A New Gold Rush.
Scharf EL, Ward AM, Ebbert JO. Scharf EL, et al. Mayo Clin Proc. 2020 Jan;95(1):200. doi: 10.1016/j.mayocp.2019.10.026. Mayo Clin Proc. 2020. PMID: 31902417 No abstract available.